Screener
Viridian Therapeutics, Inc. VRDN Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Viridian Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
FAQ
- What is Viridian Therapeutics, Inc.'s price / book?
- Viridian Therapeutics, Inc. (VRDN) reported price / book of 3.1× in Q2 2026.
- How has Viridian Therapeutics, Inc.'s price / book changed year-over-year?
- Viridian Therapeutics, Inc.'s price / book increased by 32.0% year-over-year, from 2.3× to 3.1×.
- What is the long-term trend for Viridian Therapeutics, Inc.'s price / book?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s price / book has grown at a 36.5% compound annual growth rate (CAGR), from 0.9× to 4.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Viridian Therapeutics, Inc.'s price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude